0001516551-23-000066.txt : 20230829
0001516551-23-000066.hdr.sgml : 20230829
20230829192558
ACCESSION NUMBER: 0001516551-23-000066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230825
FILED AS OF DATE: 20230829
DATE AS OF CHANGE: 20230829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grayson Paul A.
CENTRAL INDEX KEY: 0001861554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55136
FILM NUMBER: 231223482
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Skye Bioscience, Inc.
CENTRAL INDEX KEY: 0001516551
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450692882
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11250 EL CAMINO REAL, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 410-0266
MAIL ADDRESS:
STREET 1: 11250 EL CAMINO REAL, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Emerald Bioscience, Inc.
DATE OF NAME CHANGE: 20190325
FORMER COMPANY:
FORMER CONFORMED NAME: Nemus Bioscience, Inc.
DATE OF NAME CHANGE: 20141030
FORMER COMPANY:
FORMER CONFORMED NAME: LOAD GUARD LOGISTICS, INC.
DATE OF NAME CHANGE: 20121107
4
1
wk-form4_1693351547.xml
FORM 4
X0508
4
2023-08-25
0
0001516551
Skye Bioscience, Inc.
SKYE
0001861554
Grayson Paul A.
C/O SKYE BIOSCIENCE, INC.
1250 EL CAMINO REAL SUITE 100
SAN DIEGO
CA
92130
1
0
0
0
0
Common Stock
2023-08-25
4
A
0
18132596
A
18132596
D
Represents a restricted stock unit ("RSU") award that vests on the following performance milestones : 25% vests upon achieving a market cap of $125M, an additional 25% vests upon achieving a market cap of $250M, an additional 25% vests upon achieving a market cap of $400M, an additional 25% vest at an exit of $500M or greater; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs . Notwithstanding anything to the foregoing, all of the RSUS shall vest if an exit greater than $500M is achieved at an earlier date.
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
2023-08-29